Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRT9906 in Primary Fibromyalgia Syndrome
NCT03783910Phase 2Completed
- Sponsor
- Grünenthal GmbH
- Start
- Sep 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fibromyalgia (FM) comparing GRT9906 with Placebo (2 arms). Primary endpoint: Average Pain Intensity over last 3 days of treatment period. Started Sep 2005; status: completed.
02
Drugs
faxeladol
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT03783910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03783910.